An Estimate of the Cost of Hepatitis C Treatment for the Brazilian Health System.

Objectives: Hepatitis C therapy in Brazil is expensive due to the cost of antiviral drugs and demands on medical resources. The objective of this study was to estimate the direct costs per patient of chronic hepatitis C therapy in a Brazilian setting.

Method: A microcosting study from a public health system perspective.